Hyperfine, Inc.

NasdaqGM HYPR

Hyperfine, Inc. Gross Profit Margin for the Trailing 12 Months (TTM) ending September 30, 2024: 46.01%

Hyperfine, Inc. Gross Profit Margin is 46.01% for the Trailing 12 Months (TTM) ending September 30, 2024, a 11.74% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.

Hyperfine, Inc. Gross Profit Margin for the Trailing 12 Months (TTM) ending September 30, 2023 was 41.18%, a 1,457.78% change year over year.
Hyperfine, Inc. Gross Profit Margin for the Trailing 12 Months (TTM) ending September 30, 2022 was 2.64%, a 103.68% change year over year.
Hyperfine, Inc. Gross Profit Margin for the Trailing 12 Months (TTM) ending September 30, 2021 was -71.82%.

Key data

Date	Gross Profit Margin	Operating Income Margin	EBT Margin	Net Income Margin

NasdaqGM: HYPR

Hyperfine, Inc.

CEO	Ms. Maria Sainz
IPO Date	Jan. 28, 2021
Location	United States
Headquarters	351 New Whitfield Street
Employees	131
Sector	Health Care
Industries Medical Instruments Augmented Reality (AR) Pharmaceuticals

Description

Hyperfine, Inc. provides imaging, monitoring, and magnetic resonance imaging products. It offers Swoop Portable MR imaging system to address an unmet need in point-of-care medical imaging through a combination of hardware and software services. The company was incorporated in 2014 and is based in Guilford, Connecticut.

Key trends

Past 5 years